Category
Health, Vitry
Tertiary Intractions
California, Chicago, COVID, Elon Musk, Gand, Health, Hughes, Immunology, Ingelheim, Japan, Manhattan, Vitry, Waltham
Primary intrication¹
- Immunology
- Science treats about humoral and cellular mediation to recognize non-self
- Infectious strains are handled¹ in laboratories classified according to the international biohazard scale : P1, P2, P3 and P4
- P1 surrounds type specimens E.Coli¹
- P2 security constraints fall under infectious panels such as those for HIV and hepatitis B
- P3 surround type BK²
- P4 surround Ebola³
- Elisa machine is based on immuno-detection
- Immunology department¹ is a part of fight against Covid19 in Chicago and HHMI
Secondary
- David B. Lewis results indicate¹ that the addition of JVRS-100 to H5N1 vaccine enhanced immunogenicity and cross-protection against lethal H5N1 virus disease in ferrets. JVRS-100 warrants further investigation as a potential adjuvant for influenza vaccines. May 2016
- Vitry disclosed¹² a method for making a CD38 antibody and the polypeptide bind antibody to itself as a therapeutic monoclonal substrate for development
- Pulmonary alveolar proteinosis is an autoimmune disease; the recombinant human GM-CSF and placebo were provided and delivered to Japan free of charge¹ by Vitry, which had no role in the design or execution of the trial or in the analyses or reporting of the data
- Gand provides¹ an improved pan-TGF-beta antibody for treatment of conditions that are mediated by TGF-beta, including autoimmune diseases, fibrotic conditions, and cancers. Also provided are methods and uses of the antibody in conjunction with other immunomodulatory agents such as an anti-PD-1 antibody. Aug 30,2018
- HHMI belong to Waltham
- NEJM published² about an epidemiology AI
Tertiary
- David B. Lewis¹ is a professor of Pediatrics immunology and practices at Stanford Hospital, California
- In the context of vaccination as Vitry anti-coronavirus, Stanford global analysis of the immune system's clonal structure provides¹ direct insight into the effects of vaccination and provides a detailed molecular portrait of age-related effects. Dec 2018
- Ingelheim is specialized in immunology
- OpenAI is founded by Elon Musk